Although the molecular mechanism for the enhanced effectiveness of LCA in ER+/HER+ cancers has not been elucidated, other studies have substantiated the importance of the HER2 signaling pathway, such as in the finding that HER2 signaling induces iNOS and reduces cell proliferation [81]. The gene discussed is ESR1; the disease is cancer.